Any who thinks this R/S is bad is too caught up with the normal occurrences that happen in the OTC Fact is no other company in the OTC can tout this kind of revenue right after the split to drive the price and bring a end to speculation..... All we normally get is fluff news to keep it from tanking but this opportunity is of different caliber and should be looked on as such.... Good luck to all the longs and bye to everybody surpised by the enthusiasm....